Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab

Condition:   Hidradenitis Suppurativa Intervention:   Drug: Brodalumab Sponsors:   Rockefeller University;   Valeant Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - May 23, 2019 Category: Research Source Type: clinical trials